Terms: = Skin cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Prognosis
28 results:
1. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
2. Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Louveau B; Reger De Moura C; Jouenne F; Sadoux A; Allayous C; Da Meda L; Bernard-Cacciarella M; Baroudjian B; Lebbé C; Mourah S; Dumaz N
Melanoma Res; 2024 Apr; 34(2):186-192. PubMed ID: 38141200
[TBL] [Abstract] [Full Text] [Related]
3. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
4. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract] [Full Text] [Related]
6. Radiotherapy and Immunotherapy in Melanoma Brain Metastases.
Anvari A; Sasanpour P; Kheradmardi MR
Hematol Oncol Stem Cell Ther; 2023 Jan; 16(1):1-20. PubMed ID: 36634277
[TBL] [Abstract] [Full Text] [Related]
7.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract] [Full Text] [Related]
8. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
[TBL] [Abstract] [Full Text] [Related]
9. Long-term follow-up results of intensity-modulated radiotherapy with helicoïdal tomotherapy for non-metastatic breast cancers: Single centre experience.
Zolcsak Z; Loap P; Fourquet A; Kirova YM
Cancer Radiother; 2022 Sep; 26(5):654-662. PubMed ID: 35227593
[TBL] [Abstract] [Full Text] [Related]
10. ZC3H15 Correlates with a Poor prognosis and Tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract] [Full Text] [Related]
11. A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping.
Louveau B; Jouenne F; Têtu P; Sadoux A; Gruber A; Lopes E; Delyon J; Serror K; Marco O; Da Meda L; Ndiaye A; Lermine A; Dumaz N; Battistella M; Baroudjian B; Lebbe C; Mourah S
Target Oncol; 2020 Dec; 15(6):759-771. PubMed ID: 33151472
[TBL] [Abstract] [Full Text] [Related]
12. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract] [Full Text] [Related]
13. Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy.
Xu L; Cheng Z; Cui C; Wu X; Yu H; Guo J; Kong Y
J Transl Med; 2019 Jul; 17(1):245. PubMed ID: 31358010
[TBL] [Abstract] [Full Text] [Related]
14. Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
Rabin-Court A; Rodrigues MR; Zhang XM; Perry RJ
PLoS One; 2019; 14(6):e0218126. PubMed ID: 31188872
[TBL] [Abstract] [Full Text] [Related]
15. Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases.
Magnoli F; Bernasconi B; Vivian L; Proserpio I; Pinotti G; Campiotti L; Mazzucchelli L; Sessa F; Tibiletti MG; Uccella S
Cancer Genet; 2018 Dec; 228-229():28-40. PubMed ID: 30553470
[TBL] [Abstract] [Full Text] [Related]
16. Malignant Melanoma of the Nail Apparatus: A Fluorescence In Situ Hybridization Analysis of 7 Cases.
Romano RC; Shon W; Sukov WR
Int J Surg Pathol; 2016 Sep; 24(6):512-8. PubMed ID: 27185405
[TBL] [Abstract] [Full Text] [Related]
17. [Biological role and prognostic significance of genetic alterations in human malignant melanomas].
Vízkeleti L
Magy Onkol; 2015 Sep; 59(3):268-72. PubMed ID: 26339916
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathologic features and prognostic factors in patients with non-cutaneous malignant melanoma: a single-center retrospective study of 71 cases.
Zhu H; Dong D; Li F; Liu D; Wang L; Fu J; Song L; Xu G
Int J Dermatol; 2015 Dec; 54(12):1390-5. PubMed ID: 26016703
[TBL] [Abstract] [Full Text] [Related]
19. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract] [Full Text] [Related]
20. 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.
Casulo C; Schöder H; Feeney J; Lim R; Maragulia J; Zelenetz AD; Horwitz S
Leuk Lymphoma; 2013 Oct; 54(10):2163-7. PubMed ID: 23369041
[TBL] [Abstract] [Full Text] [Related]
[Next]
